'Holy herb' (Yerba santa) identified as a potential treatment for Alzheimer’s disease

Whilst analyzing a number of plant extracts, scientists have discovered that Yerba santa (Eriodictyon californicum) has notable neuroprotective properties. Yerba santa, also known as the ‘Holy Herb’, may have important implications for patients with Alzheimer’s disease.

Yerba santa plantSundry Photography | Shutterstock

Alzheimer’s disease affects around 50 million people every year, and this figure is expected to rise to 152 million in 2050, according to the 2015 World Alzheimer’s report.

Alzheimer’s disease is a degenerative neurological condition that affects a number of different brain functions, and early symptoms include minor problems with memory.

As a progressive condition, the symptoms build gradually over time and can eventually include confusion, changes in personality, hallucinations, problems with language and speech and difficulty moving around independently.

The cause of Alzheimer’s disease is not fully understood, but several risk factors have been identified that could increase a person’s chances of developing the disease.

These risk factors include increasing age, a family history of Alzheimer’s, lifestyle factors linked to cardiovascular disease, and even untreated depression.

Aging is the main risk factor for Alzheimer’s disease, and the team at the Salk Institute says there is a “strong rationale for an alternative approach to drug discovery” based on aging.

Out of a library of 400 plant extracts, the plant Yerba santa was shown to contain a highly neuroprotective flavonoid; the flavanone sterubin. Subsequent tests showed this to be a compound with “potent” neuroprotective and anti-inflammatory properties.

Used by Native Californian tribes, Yerba santa, also known as the “holy herb”, is well known for its medicinal uses. Historically it has been used to treat a number of respiratory conditions, fevers, bruises, infections, and headaches.

The sterubin found in yerba santa had significant effects on energy depletion and inflammation of microglial cells in particular. The research also found that sterubin was an effective iron chelator, with the study explaining, “iron can contribute to nerve cell damage in aging and neurodegenerative diseases.”

Publishing the study in Redox Biology, senior author of the study Dr. Pamela Maher said that “not only did sterubin turn out to be much more active than the other flavonoids in yerba santa in our assays, it appears as good as, if not better than, other flavonoids we have studied.”

Sterubin was also tested for its effect on other age-associated neurotoxicity’s linked to the build-up of misfolded aggregated proteins and inflammation present in Alzheimer’s disease, and it was found that is was effective against a number of cell death inducers.

Emphasizing the importance of age as a risk factor for Alzheimer’s disease, Maher claims:

“Researchers are looking at ways to counter aging’s effects on the brain. Our identification of sterubin as a potent neuroprotective component of a native Californian plant […] is a promising step in that direction.”

The researchers aim to study the effects of the flavanone sterubin on living Alzheimer models in mice to then determine its toxicity levels.

Using synthetic derivatives of sterubin the researchers believe that human test could be carried out soon. They finalize their study by saying:

We believe that sterubin deserves further examination in the context of [Alzheimer’s disease], as well as other neurodegenerative diseases.”

Lois Zoppi

Written by

Lois Zoppi

Lois is a freelance copywriter based in the UK. She graduated from the University of Sussex with a BA in Media Practice, having specialized in screenwriting. She maintains a focus on anxiety disorders and depression and aims to explore other areas of mental health including dissociative disorders such as maladaptive daydreaming.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Zoppi, Lois. (2019, June 20). 'Holy herb' (Yerba santa) identified as a potential treatment for Alzheimer’s disease. News-Medical. Retrieved on December 06, 2019 from https://www.news-medical.net/news/20190222/Holy-herb-(Yerba-santa)-identified-as-a-potential-treatment-for-Alzheimere28099s-disease.aspx.

  • MLA

    Zoppi, Lois. "'Holy herb' (Yerba santa) identified as a potential treatment for Alzheimer’s disease". News-Medical. 06 December 2019. <https://www.news-medical.net/news/20190222/Holy-herb-(Yerba-santa)-identified-as-a-potential-treatment-for-Alzheimere28099s-disease.aspx>.

  • Chicago

    Zoppi, Lois. "'Holy herb' (Yerba santa) identified as a potential treatment for Alzheimer’s disease". News-Medical. https://www.news-medical.net/news/20190222/Holy-herb-(Yerba-santa)-identified-as-a-potential-treatment-for-Alzheimere28099s-disease.aspx. (accessed December 06, 2019).

  • Harvard

    Zoppi, Lois. 2019. 'Holy herb' (Yerba santa) identified as a potential treatment for Alzheimer’s disease. News-Medical, viewed 06 December 2019, https://www.news-medical.net/news/20190222/Holy-herb-(Yerba-santa)-identified-as-a-potential-treatment-for-Alzheimere28099s-disease.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post